|
20 Sep 2025 |
Bank of Baroda
|
Consensus Share Price Target
|
252.08 |
273.82 |
- |
8.62 |
buy
|
|
|
|
|
16 May 2022
|
Bank of Baroda
|
Emkay
|
252.08
|
130.00
|
99.45
(153.47%)
|
Target met |
Buy
|
|
|
|
|
16 May 2022
|
Bank of Baroda
|
Emkay
|
252.08
|
130.00
|
99.45
(153.47%)
|
Target met |
Buy
|
|
|
|
|
16 May 2022
|
Bank of Baroda
|
ICICI Direct
|
252.08
|
115.00
|
99.85
(152.46%)
|
Target met |
Buy
|
|
|
|
|
16 May 2022
|
Bank of Baroda
|
Emkay
|
252.08
|
130.00
|
99.45
(153.47%)
|
Target met |
Buy
|
|
|
|
|
14 May 2022
|
Bank of Baroda
|
Prabhudas Lilladhar
|
252.08
|
125.00
|
99.45
(153.47%)
|
Target met |
Buy
|
|
|
|
|
04 Mar 2022
|
Bank of Baroda
|
Edelweiss
|
252.08
|
112.00
|
100.55
(150.70%)
|
Target met |
Neutral
|
|
|
BOB is the second largest PSU bank in the country
|
|
14 Feb 2022
|
Bank of Baroda
|
Geojit BNP Paribas
|
252.08
|
136.00
|
105.35
(139.28%)
|
Target met |
Buy
|
|
|
Bank of Baroda is an Indian multinational, public sector banking and financial services company. It currently has 8,192 branches in India and 99 overseas offices across 20 countries. The bank merged with Vijaya Bank and...
|
|
07 Feb 2022
|
Bank of Baroda
|
LKP Securities
|
252.08
|
136.00
|
113.55
(122.00%)
|
Target met |
Buy
|
|
|
In 3QFY22, Bank of Baroda (BOB) has delivered a superior result on operating and assets quality front. The fresh slippages were significantly lower at 28bn v/s 52bn in 2QFY22. Furthermore, the reduction (up-gradation & recovery) stood 70bn v/s 93bn in the previous quarter. It reported...
|
|
07 Feb 2022
|
Bank of Baroda
|
ICICI Securities Limited
|
252.08
|
125.00
|
112.95
(123.18%)
|
Target met |
Buy
|
|
|
|
|
06 Feb 2022
|
Bank of Baroda
|
Motilal Oswal
|
252.08
|
150.00
|
112.95
(123.18%)
|
Target met |
Buy
|
|
|
Bank of Baroda (BOB) reported a solid earnings performance led by a strong recovery in NII and lower provisions even as lower treasury gains impacted other income. Domestic NIM, thus, expanded 31bp QoQ to 3.2%. Advances registered strong 5.5% QoQ growth. BOB's asset quality improved sharply as fresh slippage declined to INR28.3b (annualized slippage rate of 1.6%), which coupled with healthy recoveries and write-offs resulted in sharp 86bp/58bp QoQ improvement in GNPA/NNPA ratio, respectively. PCR thus increased ~350bp to ~71%. Total...
|